Fund Holdings — ARCH Venture Management, LLC

Total Portfolio Value
$80.28M
Total Bought
$9.90M
Total Sold
$92.74M
Net Transaction
-$82.84M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Q32 BIO INC.(FIXX)0320,482+320,48205,4616.80%+5,461
CERO THERAPEUTICS HOLDINGS, INC.(CERO)01,444,296+1,444,29604,4345.52%+4,434
GOSSAMER BIO, INC.(GOSS)8,055,9168,055,91607,3519,50611.84%+2,155
SINGULAR GENOMICS SYSTEMS, INC.3,798,9263,798,92601,7481,9532.43%+206
UNITY BIOTECHNOLOGY, INC.1,004,8171,004,81701,9391,6482.05%-291
DENALI THERAPEUTICS, INC.(DNLI)381,249381,24908,1827,8239.75%-358
ERASCA, INC.(ERAS)11,055,55411,055,554023,54822,77428.37%-774
VERVE THERAPEUTICS, INC.2,008,8092,008,809028,00326,67733.23%-1,326
REVOLUTION MEDICINES, INC.(RVMD)3,233,4900-3,233,49092,7360—-92,736
Page 1 of 1
ARCH Venture Management, LLC — 13F Holdings — Q1 2024 | TickerTrail